Today: 30 June 2026
Vistra Corp (VST) stock sinks again — what to watch before Thursday trading
5 February 2026
1 min read

Vistra Corp (VST) stock sinks again — what to watch before Thursday trading

New York, Feb 4, 2026, 21:10 (EST) — Market closed.

  • Vistra shares closed down 6.9% at $142.52, extending a five-session slide.
  • Peer power names also fell, with Constellation down 6.8% and NRG off 5.4%.
  • Traders now look to Vistra’s Feb. 26 earnings and shifting U.S. nuclear-policy signals.

Vistra Corp shares fell 6.8% on Wednesday to close at $142.52.

The decline marked the stock’s fifth straight daily loss. Trading volume hit about 12.5 million shares, and Vistra ended the day roughly 35% below its 52-week high of $219.82, MarketWatch data showed.

The move came as U.S. stocks closed lower, led by another drop in big tech, with investors debating whether the AI rally has peaked. “The market is suddenly skeptical,” said Jed Ellerbroek, a portfolio manager at Argent Capital in St. Louis, after the S&P 500 fell 0.51% and the Nasdaq slid 1.51%. Reuters

Selling pressure also showed up in other U.S. power generators. Constellation Energy fell 6.8% to $250.46, and NRG Energy dropped 5.4% to $143.99.

Attention now shifts to Vistra’s next scheduled catalyst. The company has said it will report fourth-quarter and full-year 2025 results on Feb. 26 and host a conference call at 10 a.m. ET.

Vistra is an integrated retail electricity and power generation company, operating a fleet that includes natural gas and nuclear plants alongside coal, solar and battery storage, according to its company profile.

The stock’s swings have tracked shifting expectations for power demand from data centers. Meta Platforms signed 20-year agreements in January to buy power from three Vistra nuclear plants, a type of power purchase agreement (PPA) — a long-term contract to supply electricity under agreed terms.

Vistra has also been expanding on the gas side. It agreed in early January to buy Cogentrix Energy and its natural gas-fired plants for about $4.7 billion, Reuters reported at the time.

Policy is another overhang. The U.S. Nuclear Regulatory Commission said on Wednesday it is reorganizing in line with President Donald Trump’s push to speed reactor licensing, targeting a new structure by the end of September; NRC Chairman Ho Nieh said the change aims for “more efficient and timely decision making.” Critics warned the reshuffle could risk rushing licenses. Reuters

But a rebound is not automatic. If power-price expectations cool, or if the market decides the “AI power” theme was priced too far, Vistra’s share price can stay jumpy — and moves like Wednesday’s can snowball into another round of de-risking.

For the next session, investors will watch whether Vistra can steady after the five-day slide, and whether pressure on AI-linked trades spreads beyond tech. The next fixed date on the calendar is Feb. 26, when Vistra reports results and updates investors on its outlook.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
Take-Two (TTWO) stock eyes a sharp open after forecast raise, GTA VI date held
Previous Story

Take-Two (TTWO) stock eyes a sharp open after forecast raise, GTA VI date held

Micron stock sinks nearly 10% as AI jitters hit chipmakers again
Next Story

Micron stock sinks nearly 10% as AI jitters hit chipmakers again

Go toTop